Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026)

Bausch Health Companies (BHC) reported Other Non-Current Assets of $369.0 million for Q1 2026, down 2.89% on a YoY basis from $380.0 million in Q1 2025, and down 2.38% sequentially from $378.0 million in Q4 2025.

Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Other Non-Current Assets data on file, last reported at $369.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 2.89% year-over-year to $369.0 million; the trailing twelve-month figure through Mar 2026 stood at $369.0 million (down 2.89% YoY), and the FY2025 full-year result was $378.0 million, up 4.13% from the prior year.
  • Other Non-Current Assets slipped to $369.0 million in Q1 2026, from $378.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $389.0 million in Q3 2024 to a low of $307.0 million in Q4 2023.
  • A 5-year average of $347.5 million and a median of $338.0 million in 2022 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets sank 45.87% in 2022 and advanced 21.79% in 2025, its largest moves.
  • Tracing BHC's Other Non-Current Assets over 5 years: stood at $326.0 million in 2022, then declined by 5.83% to $307.0 million in 2023, then advanced by 18.24% to $363.0 million in 2024, then climbed by 4.13% to $378.0 million in 2025, then decreased by 2.38% to $369.0 million in 2026.
  • Business Quant data shows BHC's Other Non-Current Assets at $369.0 million in Q1 2026, $378.0 million in Q4 2025, and $382.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 369.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 369.00 Mn
Dec 31, 2025 378.00 Mn
Sep 30, 2025 382.00 Mn
Jun 30, 2025 388.00 Mn
Mar 31, 2025 380.00 Mn
Dec 31, 2024 363.00 Mn
Sep 30, 2024 389.00 Mn
Jun 30, 2024 329.00 Mn
Mar 31, 2024 312.00 Mn
Dec 31, 2023 307.00 Mn
Sep 30, 2023 328.00 Mn
Jun 30, 2023 325.00 Mn
Mar 31, 2023 318.00 Mn
Dec 31, 2022 326.00 Mn
Sep 30, 2022 341.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 334.00 Mn
Dec 31, 2021 340.00 Mn
Sep 30, 2021 343.00 Mn
Jun 30, 2021 596.00 Mn